A citation-based method for searching scientific literature

Daniel R Scoles, Stefan M Pulst. Adv Exp Med Biol 2018
Times Cited: 13



Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger, Stefan M Pulst, J Paul Taylor, Frank Rigo, Aaron D Gitler. Nature 2017
Times Cited: 226




List of shared articles



Times cited

The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissues associated with glaucoma pathogenesis.
Chad A Sundberg, Monika Lakk, Sharan Paul, Karla P Figueroa, Daniel R Scoles, Stefan M Pulst, David Križaj. J Comp Neurol 2021
0

Staufen1 in Human Neurodegeneration.
Sharan Paul, Warunee Dansithong, Karla P Figueroa, Mandi Gandelman, Daniel R Scoles, Stefan M Pulst. Ann Neurol 2021
4

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Ana C Silva, Diana D Lobo, Inês M Martins, Sara M Lopes, Carina Henriques, Sónia P Duarte, Jean-Cosme Dodart, Rui Jorge Nobre, Luis Pereira de Almeida. Brain 2020
18

Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2.
Polina A Egorova, Ilya B Bezprozvanny. Neurotherapeutics 2019
11

Antisense Drugs Make Sense for Neurological Diseases.
C Frank Bennett, Holly B Kordasiewicz, Don W Cleveland. Annu Rev Pharmacol Toxicol 2021
3

Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
Leeanne McGurk, Olivia M Rifai, Oksana Shcherbakova, Alexandra E Perlegos, China N Byrns, Faith R Carranza, Henry W Zhou, Hyung-Jun Kim, Yongqing Zhu, Nancy M Bonini. Hum Mol Genet 2021
0

Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.
C Frank Bennett, Adrian R Krainer, Don W Cleveland. Annu Rev Neurosci 2019
61